Top 10 Patent and Regulatory Things You Need to Know when Bringing a Biopharma Product to Canada
Canada is an attractive market for pharmaceutical manufacturers.30/04/2021
Life Sciences
Loading
Some interesting aspects of food patents in Japan
Regarding the examination of an invention of a food product with a limitation of use, there was a significant change in the Examination Guidelines for Patent and Utility Model (hereinafter, “JPO Guidelines”) and the Examination Handbook for Patent and Utility Model (hereinafter, “Examination HB”) in...Pharma patent litigation in Russia: latest trends
In Russia 2018 and 2019 have been interesting years for patent litigation18/08/2019 Natalia Gulyaeva, Hogan Lovells, Russia
EU patent court – the countdown also runs for Life Science Companies
The Agreement on a Unified Patent Court (EPC) is expected to enter into force at the beginning of 201920/09/2018 Peter von Czettritz, Preu Bohlig & Partner, Germany
Biosimilars and Trademarks Issues
Pharmaceutical products are part of a heavily regulated market20/09/2018 Robert Valenti, DLA Piper, Italy
Medical devices – new self-regulation (Finland)
The importance of self-regulation in medical technology industry increases as the new Finnish Ethical Code includes monetary sanctions20/09/2018 Hanna Paloheimo, Castrén & Snellman, Finland Hilma-Karoliina Markkanen, Castrén & Snellman, Finland
The Brazilian Universal Healthcare System: Limitations on Comprehensive Therapeutic Care
Brazil has an universal healthcare system established by the Federal Constitution, according to which the State must provide all citizens with access to healthcare by devising and putting in place economic and welfare policies targeted at reducing the risk of illnesses of all sorts, while also...20/09/2018 Camila Martino Parise, Pinheiro Neto Advogados, Brazil
New strategies in pharma patent litigation in Russia
It is known that, in the past, permanent injunctions were granted by Russian courts in patent disputes only upon actual commercialisation of the infringing product19/09/2018 Natalia Gulyaeva, Hogan Lovells, Russia
Growing Your Cannabis IP Rights
The cannabis market continues to grow worldwide with medical marijuana currently legal in 35 countries and over 30 US states and counting19/09/2018 Micheline Gravelle, Bereskin & Parr, Canada
The Best and Worst of Times? Pharma Forecast for 2019
For life sciences companies in Canada, these may be the best of times: the end of the “promise doctrine”, supplementary patent protection to compensate for regulatory delays, revamped linkage laws, and robust data protection19/09/2018 Daphne Lainson, Smart & Biggar, Canada Nancy Pei, Smart & Biggar, Canada
{{article.published}}